Form 4: Elanco CEO Jeffrey Simmons Reports Stock Transactions
SEC Form 4 Filing
Elanco Animal Health CEO Jeffrey Simmons reports the acquisition of restricted stock units and stock options, as well as the disposition of shares to cover tax liabilities.
Summary
- On March 1, 2024, Jeffrey N. Simmons, CEO and Director of Elanco Animal Health Inc., was granted 187,150 restricted stock units.
- These restricted stock units vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
- On the same date, Simmons also received stock options for 408,164 shares, vesting similarly over three years.
- Simmons disposed of 48,425 shares of common stock at $16.03 to cover his tax liability related to the vesting of previously awarded restricted stock units.
- Following these transactions, Simmons directly owns 1,367,467 shares of Elanco common stock and indirectly owns 45,000 shares through a revocable trust.
- He also directly owns options to purchase 408,164 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are part of a standard compensation package, indicating confidence in the company's future. The vesting schedule promotes long-term alignment.
Positives
- The grant of restricted stock units and stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term performance and retention.
Future Outlook
The vesting schedule of the restricted stock units and stock options suggests a focus on long-term value creation for Elanco.
Industry Context
Stock grants and options are common forms of executive compensation in the animal health industry, aligning management incentives with shareholder value.
Comparison to Industry Standards
- Executive compensation packages in the animal health industry often include a mix of salary, bonus, stock options, and restricted stock units.
- Companies like Zoetis and Merck Animal Health also utilize similar compensation structures to incentivize their executives.
- The vesting schedules are fairly standard, typically ranging from three to five years.
Stakeholder Impact
- The stock transactions have a minor impact on shareholders, primarily through potential dilution from the vesting of stock options and restricted stock units.
- Employees may view the executive compensation package as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of grant for restricted stock units and stock options, and the date of shares disposed of to cover tax liability. |
| 03/01/2025 | First vesting date for one-third of the restricted stock units and stock options. |
| 03/01/2026 | Second vesting date for one-third of the restricted stock units and stock options. |
| 03/01/2027 | Final vesting date for the remaining restricted stock units and stock options. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
| 03/01/2034 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.